Zydol-P Suspension is a combination analgesic and antipyretic formulation containing Mefenamic Acid (50mg/5ml) and Paracetamol (125mg/5ml). It is indicated for the relief of mild to moderate pain and fever associated with various conditions such as dental pain, musculoskeletal pain, dysmenorrhea, and febrile illnesses. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for inflammation and pain. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. The combination provides synergistic analgesic and antipyretic effects, enhancing efficacy while potentially minimizing the dose-related adverse effects of each component. Zydol-P Suspension is suitable for pediatric and adult patients requiring oral administration of analgesics and antipyretics. It should be used with caution in patients with hepatic or renal impairment, gastrointestinal disorders, or hypersensitivity to NSAIDs or paracetamol. Dosage must be adhered to as per medical guidance to avoid toxicity. Common adverse effects may include gastrointestinal discomfort, allergic reactions, or hepatic enzyme elevation. Consultation with a healthcare professional is recommended before use, especially in patients with pre-existing medical conditions or concurrent medication use.